BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 7796503)

  • 1. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.
    Lachurié ML; Azizi M; Guyene TT; Alhenc-Gelas F; Ménard J
    Circulation; 1995 Jun; 91(12):2933-42. PubMed ID: 7796503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressor and hormonal responses to angiotensin I infusion in healthy subjects of different angiotensin-converting enzyme genotypes.
    Chadwick IG; O'Toole L; Morice AH; Yeo WW; Jackson PR; Ramsay LE
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):485-9. PubMed ID: 9156358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced plasma levels of angiotensin-(1-7) and renin activity in preeclamptic patients are associated with the angiotensin I- converting enzyme deletion/deletion genotype.
    Velloso EP; Vieira R; Cabral AC; Kalapothakis E; Santos RA
    Braz J Med Biol Res; 2007 Apr; 40(4):583-90. PubMed ID: 17401503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme.
    Ueda S; Elliott HL; Morton JJ; Connell JM
    Hypertension; 1995 Jun; 25(6):1266-9. PubMed ID: 7768572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
    Stephan D; Grima M; Welsch M; Barthelmebs M; Vasmant D; Imbs J
    Fundam Clin Pharmacol; 1996; 10(5):474-83. PubMed ID: 8902551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population.
    Paillard F; Chansel D; Brand E; Benetos A; Thomas F; Czekalski S; Ardaillou R; Soubrier F
    Hypertension; 1999 Sep; 34(3):423-9. PubMed ID: 10489388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women.
    Umeda M; Ichikawa S; Kanda T; Sumino H; Kobayashi I
    Am J Hypertens; 2001 Mar; 14(3):206-11. PubMed ID: 11281230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of the ACE ( I/D) polymorphism on systemic and renal vascular responses to angiotensins in normotensive, normoalbuminuric Type 1 diabetes mellitus.
    Luik PT; Hoogenberg K; Kerstens MN; Beusekamp BJ; De Jong PE; Dullaart RP; Navis GJ
    Diabetologia; 2003 Aug; 46(8):1131-9. PubMed ID: 12856080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
    De'Oliveira JM; Price DA; Fisher ND; Allan DR; McKnight JA; Williams GH; Hollenberg NK
    Kidney Int; 1997 Sep; 52(3):771-7. PubMed ID: 9291199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the renin-angiotensin-aldosterone system on blood pressure response to intravenous enalaprilat in patients with hypertensive crises.
    Hirschl MM; Binder M; Bur A; Herkner H; Woisetschläger C; Bieglmayer C; Laggner AN
    J Hum Hypertens; 1997 Mar; 11(3):177-83. PubMed ID: 9175570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization.
    Hisatake S; Kiuchi S; Kabuki T; Oka T; Dobashi S; Ikeda T
    Heart Vessels; 2017 Mar; 32(3):303-308. PubMed ID: 27421979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels.
    Danser AH; Derkx FH; Hense HW; Jeunemaître X; Riegger GA; Schunkert H
    J Hypertens; 1998 Dec; 16(12 Pt 2):1879-83. PubMed ID: 9886872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA; Derkx FH; van den Meiracker AH
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of gender on the renal response to angiotensin II.
    Miller JA; Anacta LA; Cattran DC
    Kidney Int; 1999 Jan; 55(1):278-85. PubMed ID: 9893137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentration of renin-angiotensin system components in association with ACE I/D polymorphism among hypertensive subjects in response to ACE inhibitor therapy.
    Hristova M; Stanilova S; Miteva L
    Clin Exp Hypertens; 2019; 41(7):662-669. PubMed ID: 30307755
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II production.
    Azizi M; Junot C; Ezan E; Hallouin MC; Guyene T; Ménard J
    J Mol Med (Berl); 2002 Aug; 80(8):492-8. PubMed ID: 12185449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.